Advertisement
Summit Therapeutics Inc. (SMMT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
As of 02:27PM EDT. Market open.
| Previous Close | 20.59 |
| Open | 20.40 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 19.35 - 20.56 |
| 52 Week Range | 1.64 - 33.89 |
| Volume | |
| Avg. Volume | 5,038,104 |
| Market Cap | 14.257B |
| Beta (5Y Monthly) | -0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.11 |
| Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.25 |
ZacksSummit Stock Skyrockets Nearly 700% YTD: Time to Sell or Hold?
The rally in SMMT stock is driven by encouraging updates on its oncology candidate, which has the potential to become the next standard of care in the NSCLC space.
Motley FoolBillionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?
Millennium Management just initiated a position in a small biotech company developing a new cancer drug.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.